iMolview Lite

58
iMolview Lite
iMolview Lite is an Android app from Molsoft in the Education category, currently rated 4.4★ across 534 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 58: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
| 🌐 Cross-platform reach (iOS + Android) | +$33K |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Education engagement | ~85 installs / rating |
| 🔁 Education D30 retention | 18% |
| 📍 DAU / MAU stickiness | 0.30 |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 38/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.43★ across 534 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 3169d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (3169d since update).
💰 Forecast Revenue / mo
MODEL| Mature app (13y old)METRIC | +$1,500 | |
| Good rating (4.4★)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (534 ratings)METRIC | +$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- iMolview Lite
- Developer
- Molsoft
- Bundle ID
- com.molsoft.imolview
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.molsoft.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $399/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth534 ratings+27% lifetimeShow 3-year history estimate ▾
📝 About this app
iMolview lets you browse and view in 3D protein and DNA structures from Protein Data Bank, drug molecules from DrugBank, and small molecules from Pubchem. Search for drug names like 'ibuprofen' or 'gefitinib' in DrugBank, or proteins like 'insulin' or 'thyroid receptor' or pdb code in PDB. Information associated with each molecule in these databases is also at your fingertips. Sync and view your own structure files via iMolview folder on your sdcard.… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
Why medium confidence: 534 ratings · no founder-verified revenue (model estimate only).




